Strategic acquisitions Firstline was acquired by DoseMe in November 2025, indicating potential alignment with DoseMe’s ecosystem and opportunities to offer integrated clinical decision support and antimicrobial stewardship capabilities within DoseMe’s platform for broader hospital networks.

Hospital partnerships Recent and notable partnerships with NYC Health + Hospitals and collaboration with WHO show strong traction in large health systems and global public health initiatives, suggesting enterprise-level sales opportunities with large hospital networks and international organizations.

AMR and ID focus Core offerings around antimicrobial stewardship, infection prevention and control, and local antibiogram data position Firstline to cross-sell to hospitals expanding ID and AMR programs, especially in care settings adopting decision support to meet regulatory and clinical guidelines.

Community and free tier The free Firstline Community platform for healthcare professionals creates a funnel for expanding platform usage, clinician engagement, and upside potential for paid institutional deployments and premium features.

Global research alignment Partnerships with WHO and global health initiatives indicate openness to multi-region deployments and consortium-style deals, providing avenues for multinational contracts and collaborations with academic, government, and NGO buyers.